INCIDENCE OF ATYPICAL GLANDULAR CELLS OF UNCERTAIN SIGNIFICANCE IN CERVICAL CYTOLOGY FOLLOWING INTRODUCTION OF THE BETHESDA SYSTEM

Citation
Gl. Eddy et al., INCIDENCE OF ATYPICAL GLANDULAR CELLS OF UNCERTAIN SIGNIFICANCE IN CERVICAL CYTOLOGY FOLLOWING INTRODUCTION OF THE BETHESDA SYSTEM, Gynecologic oncology, 67(1), 1997, pp. 51-55
Citations number
11
Categorie Soggetti
Oncology,"Obsetric & Gynecology
Journal title
ISSN journal
00908258
Volume
67
Issue
1
Year of publication
1997
Pages
51 - 55
Database
ISI
SICI code
0090-8258(1997)67:1<51:IOAGCO>2.0.ZU;2-2
Abstract
Objective. To establish the frequency of the atypical glandular cells of uncertain significance (AGCUS) category, and its subcategories, as defined by the Bethesda System (TBS). Methods. Our computerized record s of cervical/vaginal cytology specimens submitted from January 1, 199 3, through December 31, 1995, were retrospectively reviewed for specim ens diagnosed as AGCUS. When appropriate, our subcategory of ''AGCUS f avor premalignant/malignant lesion'' was further qualified as ''favor endocervical adenocarcinoma in situ'' or ''suspicious for endometrial carcinoma.'' The number of specimens and patients diagnosed for each s ubcategory were grouped by calendar year. Differences in frequency bet ween time periods were tested for statistical significance using chi(2 ) analysis. Results. AGCUS was diagnosed in 1181 of 177,715 submitted specimens (0.66%). The frequency of subcategories was as follows: ''fa vor reactive'' (65%), ''unable to further classify'' (30%), ''favor pr emalignant/malignant'' (2.9%), ''suspicious for endometrial carcinoma' ' (1.9%), and ''favor endocervical adenocarcinoma in situ'' (0.4%). Fr om 1993 to 1995 there was an increase in the rate of diagnosis of AGCU S (0.55 to 0.73%; P < 0.001) and a decrease in the percentage of speci mens with AGCUS subclassified as ''favor premalignant/malignant'' (6.2 to 0.5%; P < 0.001). Other subcategories showed no significant change in frequency over this time period. The rate of biopsy-proven preinva sive or invasive lesions in AGCUS patients also showed no significant change from year to year over this time period. Conclusion. The AGCUS diagnosis can be anticipated at a low but consistent rate from a cytol ogy laboratory using TBS. Any comparison of laboratories should take i nto consideration the change in reporting frequencies that occurs as p art of the ''learning curve'' following introduction of TBS reporting. Uniform diagnostic criteria and additional reports with large numbers of cytologic specimens will be needed to establish the expected frequ ency of AGCUS and its subcategories. (C) 1997 Academic Press.